The Protecting Access to Medicare Act, law since 2014, is being delayed by the Trump administration, according to a Kaiser Health News report via NPR.
Federal officials “have yet to implement” the law, which covers such diagnostic procedures as CT, PET, nuclear medicine and MR, according to Kaiser Health News (KHN). They have now pushed the start date to January 2020 — from 2018 — and the Centers for Medicare & Medicaid Services is making the first year one of "testing," so the agency will still cover scans even if doctors don't check the guidelines first. Plans now call for determining overuse penalties sometime in the 2022-2023 range, said the news service.
Story Continues Below Advertisement
Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.
The law requires practitioners ordering “advanced diagnostic imaging service” for a Medicare patient to consult with a qualified Clinical Decision Support Mechanism — or guidelines — with the aim of cutting down on unneeded tests that can waste money and harm patients. Those who over-order could face penalties.
Critics worry such delays will mean Medicare pays millions for unneeded tests and patients get hit with unnecessary radiation.
"These delays mean that many more inappropriate imaging procedures will be performed, wasting financial resources and subjecting patients to services they do not need," Gary Young, director of the Northeastern University Center for Health Policy and Healthcare Research in Boston, told the news service, noting that, "If this program were implemented stringently, you would certainly reduce inappropriate imaging to some degree."
The law zeros in on testing with fee-for-service Medicare patients — health insurers have already been balking at paying for such tests without some form of preauthorization.
"CMS expects to learn more about the prevalence of imaging orders identified as 'not appropriate' under this program when we begin to identify outlier ordering professionals," a CMS spokeswoman told KHN.
The focus of the use of guidelines is on non-workflow disrupting tests, so patients in the emergency room and hospital aren't part of the program. CMS is focusing guideline-use on situations typically involving less time-critical testing, such as for headaches, heart disease, and back, neck, and shoulder pain.
Some complain that the law is overreaching and burdensome.